From the First Dental MRI to Orthodontic AI: Four FDA Clearances Reshaping Dentistry

The U.S. Food and Drug Administration has granted clearances to several groundbreaking dental technologies, including the first dental-dedicated MRI system and advanced orthodontic AI platforms. These innovations from companies like Dentsply Sirona, Siemens Healthineers, and Orca Dental AI signal a shift toward non-ionizing imaging and automated diagnostic support. For the dental industry, these developments promise more precise soft-tissue assessment and streamlined workflows in specialized fields such as endodontics, periodontics, and orthodontics.

Dentsply Sirona and Siemens Healthineers received FDA clearance on March 9 for the MAGNETOM Free.Max Dental Edition, marking the introduction of the first MRI system dedicated specifically to dental applications. Unlike traditional dental imaging methods, this system utilizes non-ionizing radiation and offers superior soft-tissue contrast through a specialized dental coil and software designed for dentomaxillofacial imaging. Clinical trials validated the system's efficacy in differentiating active inflammation from scar tissue and non-invasively assessing tooth pulp vitality, with an average workflow time of less than 20 minutes.

The new MRI technology is primarily intended for use in hospitals, universities, and large-scale dental clinics to complement existing intraoral, panoramic, and CBCT imaging. By providing detailed visualization of teeth alongside adjacent nerves and soft tissues, the system is expected to impact multiple specialties, including periodontics, orthodontics, and the management of temporomandibular joint disorders. Andreas Schneck, head of magnetic resonance at Siemens Healthineers, noted that the validation of dental MRI (ddMRI) through clinical trials paves the way for a new clinical field that benefits both practitioners and patients.

On March 24, Orca Dental AI announced that its CEPHX3D platform received FDA clearance for 3D imaging, positioning it as a significant advancement in orthodontic diagnostic support. The company reports that this clearance makes CephX a unique orthodontic AI diagnostic support platform with FDA clearance for 3D imaging capabilities. This move highlights the accelerating trend of integrating artificial intelligence into dental workflows to improve diagnostic accuracy and efficiency in orthodontic treatment planning, reflecting a broader industry move toward data-driven dentistry.